Drug Company Trained Sellers to Ignore Drug Risks

Eli Lilly & Co reportedly trained sales people to downplay the risks associated with the drug Zyprexa and to promote its use beyond the approved treatments for schizophrenia and bipolar disorder. The drug, which is linked to weight gain and diabetes, was pushed to primary-care and nursing home doctors with no regard to the risks. Read more here.

Lawyer Monthly - Legal Awards Winner
The National Trial Lawyers
Elder Care Matters Alliance
American Association for Justice
Fellow Litigation Counsel of America
Super Lawyers